drugset / Trial / NCT00519636

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

NCT00519636

Phase 4 Completed 360 enrolled GlaxoSmithKline
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this replicate study to FFU105924 is to provide data on subject preference of FFNS as compared with FPNS.

Timeline

Start
2007-08
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Furoate Other / unclassified 110 ug Intranasal
Comparator Fluticasone propionate Other / unclassified 200 ug Intranasal